Bioactivation of the pulmonary toxicants naphthalene and 1-nitronaphthalene by rat CYP2F4

Journal of Pharmacology and Experimental Therapeutics

Volumn 312, Issue 2, 2005, Pages 857-865

  Baldwin, R Michael ^a   Shultz, Michael A ^a   Buckpitt, Alan R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 NITRONAPHTHALENE; CYTOCHROME P450; CYTOCHROME P450 2F1; CYTOCHROME P450 2F2; CYTOCHROME P450 2F4; EPOXIDE; HEME; NAPHTHALENE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CLARA CELL; CONTROLLED STUDY; DRUG METABOLISM; DRUG SENSITIVITY; EPOXIDATION; GLUTATHIONE METABOLISM; IMMUNOREACTIVITY; LUNG; LUNG TOXICITY; MALE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; RAT; STEREOCHEMISTRY;

ANIMALS; BACULOVIRIDAE; BIOTRANSFORMATION; CLONING, MOLECULAR; CYTOCHROME P-450 ENZYME SYSTEM; DNA, COMPLEMENTARY; GENE LIBRARY; INDICATORS AND REAGENTS; ISOENZYMES; KINETICS; LUNG DISEASES; MALE; NAPHTHALENES; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 13244258413     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.075440     Document Type: Article

References (41)

1. Agency for Toxic Substances and Disease Registry (ATSDR) (1995) Toxicological Profile for Naphthalene, 1-Methylnaphthalene, 2-Methylnaphthalen, pp 1-200, U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry, Atlanta, GA.
2. Andersen MR, Farin FM, and Omiecinski CJ (1998) Quantification of multiple human cytochrome P450 mRNA molecules using competitive reverse transcriptase-PCR. DNA Cell Biol 17:231-238.
3. Baldwin RM, Jewell WT, Fanucchi MV, Plopper CG, and Buckpitt AR (2004) Comparison of pulmonary/nasal CYP2F expression levels in rodents and rhesus macaque. J Pharmacol Exp Ther 309:127-136.
4. Bryan CL and Jenkinson SG (1987) Species variation in lung antioxidant enzyme activities. J Appl Physiol 63:597-602.
5. Buckpitt AE, Buonarati M, Avey LB, Chang AM, Morin D, and Plopper CG (1992) Relationship of cytochrome P450 activity to Clara cell cytotoxicity. II. Comparison of stereoselectivity of naphthalene epoxidation in lung and nasal mucosa of mouse, hamster, rat and rhesus monkey. J Pharmacol Exp Ther 261:364-372.
6. Buckpitt AE, Castagnoli N Jr, Nelson SD, Jones AD, and Bahnson LS (1987) Stereoselectivity of naphthalene epoxidation by mouse, rat, and hamster pulmonary, hepatic and renal microsomal enzymes. Drug Metab Dispos 15:491-498.
7. Buckpitt AE, Chang AM, Weir A, Van Winkle L, Duan X, Philpot E, and Plopper C (1995) Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats and hamsters. Mol Pharmacol 47:74-81,
8. Evert B, Eichelbaum M, Haubruck H, and Zanger UM (1997) Functional properties of CYP2D6 1 (wild-type) and CYP2D6 7 (His324Pro) expressed by recombinant baculovirus in insect cells. Naunyn-Schmiedeberg's Arch Pharmacol 355:309-318.
9. Grosovsky AJ, Sasaki JC, Arey J, Eastmond DA, Parks KK, and Atkinson E (1999) Evaluation of the potential health effects of the atmospheric reaction products of polycyclics romatic hydrocarbons. Res Rep Health Eff Inst 84:1-22.
10. Guengerich LP (1994) Analysis and characterization of enzymes, in Principles and Methods of Toxicology, 3rd ed (Hayes AW ed) pp 1269, Raven Press Ltd., New York.
11. Hakkola J, Raunio H, Purkunen R, Pelkonen O, Saarikoski S, Cresteil T, and Pasanen M (1996) Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. Biochem Pharmacol 52:379-383.
12. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2002) Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. IARC Monogr Eval Carcinog Risks Hum 82:1-556.
13. Ingelman-Sundberg M (2002) Polymorphism of cytochrome P450 and xenobiotic toxicity. Toxicology 181-182:447-452.
14. Kitagawa K, Kunugita N, Kitagawa M, and Kawamoto T (2001) CYP2A6*6, a novel polymorphism in cytochrome P450 2A6, has a single amino acid substitution (H128Q) that inactivates enzymatic activity. J Biol Chem 276:17830-17835.
15. Lanza DL, Code E, Crespi CL, Gonzalez FJ, and Yost GS (1999) Specific dehydrogenation of 3-methylindole and epoxidation of naphthalene by recombinant human CYP2F1 expressed in lymphoblastoid cells. Drug Metab Dispos 27:798-803.
16. Lorenz J, Glatt HE, Fleischmann E, Ferlinz E, and Oesch F (1984) Drug metabolism in man and its relationship to that in three rodent species: monooxygenase, epoxide hydrolase and glutathione S-transferase activities in subcellular fractions of lung and liver. Biochem Med 32:43-56.
17. Nagata K, Martin BM, Gillette JE, and Sasame HA (1990) Isozymes of cytochrome P-450 that metabolize naphthalene in liver and lung of untreated mice. Drug Metab Dispos 18:557-564.
18. National Toxicology Program (1992) Toxicology and carcinogenesis studies of naphthalene (CAS no. 91-20-3) in B6C3F1 mice (inhalation studies). Natl Toxicol Program Tech Rep Ser 410:1-172.
19. National Toxicology Program (2000) Toxicology and carcinogenesis studies of naphthalene (CAS no. 91-20-3) in F344/N rats (inhalation studies). Natl Toxicol Program Tech Rep Ser 500:1-173.
20. Nichols WK, Mehta E, Skordos K, Mace K, Pfeifer AM, Carr BA, Minko T, Burchiel SW, and Yost GS (2003) 3-Methylindole-induced toxicity to human bronchial epithelial cell lines. Toxicol Sci 71:229-236.
21. Nishimura M, Yaguti H, Yoshitsugu H, Naito S, and Satoh T (2003) Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi 123:369-375.
22. Omura T and Sato R (1964) The carbon monoxide binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239:2370-2378.
23. Pacifici GM, Boobis AR, Brodie MJ, McManus ME, and Davies DS (1981) Tissue and species differences in enzymes of epoxide metabolism. Xenobiotica 11:73-79.
24. Plopper CG, Suverkropp C, Morin D, Nishio S, and Buckpitt A (1992) Relationship of cytochrome P-450 activity to Clara cell cytotoxicity. I. Histopathologic comparison of the respiratory tract of mice, rats and hamsters after parenteral administration of naphthalene. J Pharmacol Exp Ther 261:353-363.
25. Rasmussen RE, Do DH, Kim TS, and Dearden LC (1986) Comparative cytotoxicity of naphthalene and its monomethyl- and mononitro-derivatives in the mouse lung. J Appl Toxic 6:13-20.
26. Ritter JK, Owens IS, Negishi M, Nagata K, Sheen YY, Gillette JR, and Sasame HA (1991) Mouse pulmonary cytochrome P-450 naphthalene hydroxylase: cDNA cloning, sequence and expression in Saccharomyces cerevisiae. Biochemistry 30:11430-11437.
27. Sauer JM, Eversole RR, Lehmann CL, Johnson DE, and Beuving LJ (1997) An ultrastructural evaluation of acute 1-nitronaphthalene induced hepatic and pulmonary toxicity in the rat. Toxicol Lett (Shannon) 90:19-27.
28. Sheets PL, Yost GS, and Carlson GP (2004) Benzene metabolism in human lung cell lines BEAS-2B and A549 and cells overexpressing CYP2F1. J Biochem Mol Toxicol 18:92-99.
29. Shultz MA, Choudary PV, and Buckpitt AR (1999) Role of murine cytochrome P-450 2F2 in metabolic activation of naphthalene and metabolism of other xenobiotics. J Pharmacol Exp Ther 290:281-288.
30. Shultz MA, Morin D, Chang AM, and Buckpitt A (2001) Metabolic capabilities of CYP2F2 with various pulmonary toxicants and its relative abundance in mouse lung subcompartments. J Pharmacol Exp Ther 296:510-519.
31. Simmonds AC, Reilly CA, Baldwin RM, Ghanayem BI, Lanza DL, Yost GS, Collins KS, and Forkert PG (2004) Bioactivation of 1,1-dichloroethylene to its epoxide by CYP2E1 and CYP2F enzymes. Drug Metab Dispos 32:1032-1039.
32. Simons PC and Vander Jagt DL (1981) Purification of glutathione S-transferases by glutathione-affinity chromatography. Methods Enzymol 77:235-237.
33. Strobel HW and Dignam JD (1978) Purification and properties of NADPH-cytochrome P-450 reductase. Methods Enzymol 52:89-96.
34. Thornton-Manning J, Appleton ML, Gonzalez FJ, and Yost GS (1996) Metabolism of 3-methylindole by vaccinia-expressed P450 enzymes: correlation of 3-methyleneindolenine formation and protein-binding. J Pharmacol Exp Ther 278:21-29.
35. Verschoyle RD, Carthew P, Wolf CR, and Dinsdale D (1993) 1-Nitronaphthalene toxicity in rat lung and liver: effects of inhibiting and inducing cytochrome P450 activity. Toxicol Appl Pharmacol 122:208-213.
36. Wang H, Lanza DL, and Yost GS (1998) Cloning and expression of CYP2F3, a cytochrome P450 that bioactivates the selective pneumotoxins 3-methylindole and naphthalene. Arch Biochem Biophys 349:329-340.
37. Warren DL, Brown DL Jr, and Buckpitt AE (1982) Evidence for cytochrome P-450 mediated metabolism in the bronchiolar damage by naphthalene. Chem-Biol Interact 40:287-303.
38. Watt KC and Buckpitt AR (2000) Species differences in the regio- and stereoselectivity of 1-nitronaphthalene metabolism. Drug Metab Dispos 28:376-378.
39. Watt KC, Morin DM, Kurth MJ, Mercer RS, Plopper CG, and Buckpitt AR (1999) Glutathione conjugation of electrophilic metabolites of 1-nitronaphthalene in rat tracheobronchial airways and liver: identification by mass spectrometry and proton nuclear magnetic resonance spectroscopy. Chem Res Toxicol 12:831-839.
40. West JA, Pakehham G, Morin D, Fleschner CA, Buckpitt AR, and Plopper CG (2001) Inhaled naphthalene causes dose dependent Clara cell cytotoxicity in mice but not in rats. Toxicol Appl Pharmacol 173:114-119.
41. Yamano S, Tatsuno J, and Gonzalez FJ (1990) The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry 29:1322-1329.